GLP-1 pillar guide
GLP-1 medicines in India: suitability, safety and support
A practical starting point for people researching incretin-based medicines, doctor-guided evaluation, or support after a prescription from a qualified clinician.
What GLP-1 means
GLP-1 is a hormone pathway involved in appetite, digestion and blood-glucose regulation. Some prescription medicines act on this pathway; tirzepatide acts on GIP and GLP-1 pathways.
Medicine names, approved uses and availability differ by product and country. Category information is not a personal recommendation.
How a doctor considers suitability
A doctor may consider weight history, metabolic risk, current medicines, previous treatment, pregnancy plans, digestive history and other safety factors.
The interactive suitability check can organise information, but it cannot diagnose or approve treatment.
- Review the molecule guides for semaglutide and tirzepatide.
- Read the side-effect and safety pages before discussing treatment.
- Use nutrition, protein and existing-treatment support pages after a prescription where relevant.
Safety, food, muscle and follow-up
Reduced appetite can make hydration, protein intake and meal quality harder. Side effects may also affect eating and daily routines.
Structured follow-up helps users prepare questions, track symptoms and recognise when to contact their prescribing doctor or seek urgent care.
Costs and the ZentraHealth role
Medicine, clinician, laboratory and support costs are separate. ZentraHealth offers doctor-review coordination and WhatsApp-first support; it does not sell prescription medicines.
The Companion Plan costs ₹3,999 per month for three months. Medicines, prescriptions, labs, emergency care and guaranteed outcomes are separate.
Frequently asked questions
Is every GLP-1 medicine used for weight management?
No. Approved uses vary by product and country. A qualified doctor should verify the indication and decide what, if anything, is appropriate.
Does ZentraHealth prescribe or sell GLP-1 medicines?
No. ZentraHealth provides education, care navigation, doctor-review coordination and support; it does not sell prescription medicines.
Where should I start?
Start with the educational suitability page, then use the interactive check if you want to organise information for a possible doctor-guided review.
References and source material
These sources support the educational context on this page. Product labels and recommendations can change; local medical evaluation remains essential.
- Wegovy (semaglutide) prescribing information — U.S. Food and Drug Administration
- Zepbound (tirzepatide) prescribing information — U.S. Food and Drug Administration
Continue with the route that fits your situation
Use the suitability guide if you are still researching, or activate structured support when you are ready. Payment never guarantees a prescription or medical suitability.